 |
November 12, 2024 |
|
Dear Advocate,
As we continue to grapple with the results of the US presidential election and what this means for our work and for global health evidence- and rights-based policies and programs generally, we wanted to share a range of new tools and resources you may find helpful in your advocacy for choice, science and rights. |
| Injectable Lenacapavir for PrEP |
|
|
| |
 |
|
|
Choice, Not Miracles.
AVAC Communications Director, Kenyon Farrow breaks down the potential of LEN to make choice a reality.
|
| View on Instagram |
 |
|
|
|
|
|
|
|
|
| Additional LEN Resources |
|
|
|
|
|
| Webinars on the STI Pipeline, Advances in Research Ethics, and Money for the DVR and More! |
|
|
| |
|
|
| November 19, 2024 @ 9:30am EST/17:30 EAT |
|
|
 |
|
|
|
|
|
|
 |
|
|
| Launch of CIFF/Global Fund Initiative for the PrEP Ring |
|
|
|
This webinar helped kick-off the launch of the PrEP Ring Early Market Access Vehicle (EMAV), recently announced by CIFF in partnership with the Global Fund. This initiative will provide up to US$2 million to purchase up to 150,000 dapivirine vaginal rings in countries implementing Global Fund HIV grants.
|
|
|
|
 |
|
|
PxWire, Volume 14, Issue 4
The latest PxWire discusses the newest trends in global PrEP uptake, what we can expect from lenacapavir, what's on the R&D prevention pipeline and a roundup of useful resources.
|
|
|
|
|
|
|
|
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences | Unsubscribe
|
|
|
